A fly with an ointment: Bcl-2 as an anti-mutator in tumors.
Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia 19104, USA. eyal@mail.med.upenn.edu
Eyal
E
Gottlieb
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology / Q000627:therapeutic use; D017209:Apoptosis / Q000235:genetics*; D002869:Chromosome Aberrations; D004260:DNA Repair; D018450:Disease Progression; D019254:Genes, bcl-2; D016158:Genes, p53; D006801:Humans; D008954:Models, Biological; D009154:Mutation / Q000235:genetics*; D009361:Neoplasm Invasiveness; D009362:Neoplasm Metastasis; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors / Q000235:genetics / Q000502:physiology*; D009369:Neoplasms / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000037:antagonists & inhibitors / Q000502:physiology*; D016159:Tumor Suppressor Protein p53 / Q000172:deficiency / Q000502:physiology*
D009363:Neoplasm Proteins; D019253:Proto-Oncogene Proteins c-bcl-2; D016159:Tumor Suppressor Protein p53